Title
International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries
Date Issued
01 August 2021
Access level
open access
Resource Type
journal article
Author(s)
Ocampo-Candiani J.
Ramos-Cavazos C.J.
Arellano-Mendoza M.I.
Arenas-Guzmán R.
Beirana-Palencia A.
Salmon-Demongin A.
Welsh-Hernández E.
Cabo H.A.
Gómez-Flores M.
Dominguez-Cherit J.
Criado P.R.
Castro-López H.
Alfaro-Sánchez A.B.
García-Vargas A.
Cohen-Sabban E.N.
Fich F.
Galimberti G.
Gatti C.F.
López-Estebaranz J.L.
Lupi O.
Olmos-Pérez M.
Pérez-Alfonzo R.
Publisher(s)
John Wiley and Sons Inc
Abstract
Background: The infection by coronavirus disease 2019 (COVID-19) has been associated with multiple cutaneous manifestations, although characterization of them in Hispanic patients with darker skin phototypes is lacking. The objective of this study is to characterize the clinical dermatological manifestations associated with COVID-19 infection in cases with few or without general symptoms in patients from Latin America. Methods: Cross-sectional study using a questionnaire that was made for health professionals (physicians with a specialty in dermatology) to investigate dermatological lesions associated with COVID-19 infection in patients from 25 countries of Latin America. The survey was active from June 9 to July 30, 2020. Results: In this study, information was collected from a total of 347 patients. We found a female gender predominance: 179/347 (51.6%). The mean age at presentation was 40.87 years. The most frequent dermatological manifestations were maculopapular rash and urticarial lesions, followed by papulovesicular lesions, vesicular lesions, chilblain-like lesions, papular lesions, ecchymosis, petechial purpura, pityriasis rosea-like lesions, pruritus, palmoplantar dysesthesias, transient livedo, acral necrosis, palpable purpura, livedo racemosa, and retiform purpura. As far as we know, there are no previous reports of pruritus and palmoplantar dysesthesias. Conclusions: This registry emphasizes skin manifestations as an important criterion for establishing the diagnosis of COVID-19 infection in Latin American countries. This information will be useful for the early identification of suspected cases by health professionals (dermatologists and nondermatologists) and will allow contact tracing to mitigate the impact on health systems at different levels.
Start page
956
End page
963
Volume
60
Issue
8
Language
English
OCDE Knowledge area
Dermatología, Enfermedades venéreas
Scopus EID
2-s2.0-85105668291
PubMed ID
Source
International Journal of Dermatology
ISSN of the container
00119059
Sources of information: Directorio de Producción Científica Scopus